PTC Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 8 | -$1.27 | -$1.27 | -$1.27 |
| Q2 2024 | 8 | -$1.12 | -$1.12 | -$1.12 |
| Q3 2024 | 10 | -$2.06 | -$0.90 | -$1.52 |
| Q4 2024 | 8 | -$1.41 | -$1.41 | -$1.41 |
| Q1 2025 | 9 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2025 | 9 | -$0.87 | -$0.87 | -$0.87 |
| Q3 2025 | 9 | -$0.77 | -$0.77 | -$0.77 |
| Q4 2025 | 9 | -$0.37 | -$0.37 | -$0.37 |
| Q1 2026 | 8 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2026 | 8 | -$0.20 | -$0.20 | -$0.20 |
| Q3 2026 | 8 | -$0.00 | -$0.00 | -$0.00 |
| Q4 2026 | 8 | $0.13 | $0.13 | $0.13 |
| Q1 2027 | 8 | $0.67 | $0.67 | $0.67 |
| Q2 2027 | 8 | $0.70 | $0.70 | $0.70 |
| Q3 2027 | 8 | $0.71 | $0.71 | $0.71 |
| Q4 2027 | 8 | $2.89 | $2.89 | $2.89 |
PTC Therapeutics, Inc. Earnings Date And Information
PTC Therapeutics, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-1.16 earnings per share for the quarter, missing analysts' consensus estimates of $-1 by $0.16. The company had revenue of 186.70 M for the quarter and had revenue of 937.82 M for the year. PTC Therapeutics, Inc. has generated $-8 earnings per share over the last year ($-8.37 diluted earnings per share) and currently has a price-to-earnings ratio of -6.56. PTC Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
PTC Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$1.00 | -$1.29 | -0.29 | $183.28 M | $186.70 M |
| 04/25/2024 | Q1 2024 | -$1.21 | -$1.20 | 0.01 | $210.12 M | |
| 02/29/2024 | Q4 2023 | $0.29 | -$2.06 | -2.35 | $307.06 M | |
| 10/26/2023 | Q3 2023 | -$0.85 | -$1.76 | -0.91 | $210.23 M | $196.58 M |
| 08/03/2023 | Q2 2023 | -$1.58 | -$2.66 | -1.08 | $206.99 M | $213.81 M |
| 04/27/2023 | Q1 2023 | -$1.64 | -$1.88 | -0.24 | $220.38 M | |
| 02/21/2023 | Q4 2022 | -$1.96 | -$2.35 | -0.39 | $167.41 M | |
| 10/27/2022 | Q3 2022 | -$1.37 | -$1.53 | -0.16 | $178.52 M | $217.13 M |
| 08/04/2022 | Q2 2022 | -$1.67 | -$2.13 | -0.46 | $162.12 M | $165.53 M |
| 05/03/2022 | Q1 2022 | -$1.55 | -$1.78 | -0.23 | $148.74 M | |
| 02/22/2022 | Q4 2021 | -$1.79 | -$2.03 | -0.24 | $165.23 M | |
| 10/28/2021 | Q3 2021 | -$1.78 | -$1.89 | -0.11 | $120.44 M | $138.74 M |
| 07/29/2021 | Q2 2021 | -$1.84 | -$1.68 | 0.16 | $110.13 M | $116.68 M |
| 05/04/2021 | Q1 2021 | -$1.59 | -$1.83 | -0.24 | $117.94 M | |
| 02/25/2021 | Q4 2020 | -$0.90 | -$1.08 | -0.18 | $118.86 M | |
| 10/29/2020 | Q3 2020 | -$1.10 | -$1.03 | 0.07 | $112.21 M | $118.40 M |
| 08/05/2020 | Q2 2020 | -$1.29 | -$2.78 | -1.49 | $82.04 M | $75.24 M |
| 04/30/2020 | Q1 2020 | -$1.16 | -$1.81 | -0.65 | $68.26 M | |
| 03/02/2020 | Q4 2019 | -$0.53 | -$1.25 | -0.72 | $96.46 M | |
| 10/29/2019 | Q3 2019 | -$1.06 | $73.03 M | $71.42 M |
PTC Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is PTC Therapeutics, Inc.'s earnings date?
PTC Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
How can I listen to PTC Therapeutics, Inc.'s earnings conference call?
The conference call for PTC Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read PTC Therapeutics, Inc.'s conference call transcript?
The conference call transcript for PTC Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does PTC Therapeutics, Inc. generate each year?
PTC Therapeutics, Inc. (:PTCT) has a recorded annual revenue of $937.82 M.
-
How much profit does PTC Therapeutics, Inc. generate each year?
PTC Therapeutics, Inc. (:PTCT) has a recorded net income of $937.82 M. PTC Therapeutics, Inc. has generated $-8.37 earnings per share over the last four quarters.
-
What is PTC Therapeutics, Inc.'s price-to-earnings ratio?
PTC Therapeutics, Inc. (:PTCT) has a price-to-earnings ratio of -6.56 and price/earnings-to-growth ratio is -0.37.
